(R)-pentaisovalerylsucrose - Compound Card

(R)-pentaisovalerylsucrose

Select a section from the left sidebar

(R)-pentaisovalerylsucrose

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Glycoside
Canonical Smiles OCC1O[C@@H](O[C@]2(CO)O[C@@H]([C@H]([C@H]2C(=O)CC(C)C)OC(=O)CC(C)C)CO)C(C(C1OC(=O)CC(C)C)OC(=O)CC(C)C)OC(=O)CC(C)C
InChI InChI=1S/C37H62O15/c1-19(2)11-24(41)31-32(47-27(42)12-20(3)4)26(17-39)51-37(31,18-40)52-36-35(50-30(45)15-23(9)10)34(49-29(44)14-22(7)8)33(25(16-38)46-36)48-28(43)13-21(5)6/h19-23,25-26,31-36,38-40H,11-18H2,1-10H3/t25?,26-,31-,32-,33?,34?,35?,36+,37+/m1/s1
InChIKey BEXQOZDGVJTAQV-ZXVBSIBUSA-N
Formula C37H62O15
HBA 15
HBD 3
MW 746.89
Rotatable Bonds 20
TPSA 210.65
LogP 2.86
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 52
Formal Charge 0
Fraction CSP3 0.86
Exact Mass 746.41
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Vernonia guineensis Asteraceae Plantae 3032568

Showing of synonyms

  • Toyang NJ, Wabo HK, et al. (2012). In vitro anti-prostate cancer and ex vivo antiangiogenic activity of Vernonia guineensis Benth. (Asteraceae) tuber extracts.. Journal of ethnopharmacology,2012, 141(3), 866-871. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCC1OC2CCCCO2

Level: 1

Mol. Weight: 746.89 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 746.89 g/mol

Structure

SMILES: C1CCOC1

Level: 0

Mol. Weight: 746.89 g/mol

Cytotoxic

Absorption

Caco-2 (logPapp)
-5.21
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.04
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
131.49

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.41
Plasma Protein Binding
63.67
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
9.41
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.49
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.24
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
8.88
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-242324.76
Rat (Acute)
4.9
Rat (Chronic Oral)
4.02
Fathead Minnow
319.6
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
22605.61
Hydration Free Energy
-2.92
Log(D) at pH=7.4
3.56
Log(P)
6.04
Log S
-4.35
Log(Vapor Pressure)
-733.86
Melting Point
110.33
pKa Acid
5.98
pKa Basic
-0.54

No predicted protein targets found for this compound.

Download SDF